These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 22989537)
41. A Novel Missense Bletsis P; Metzger R; Nelson JA; Gasparini J; Alsayed M; Milas M AACE Clin Case Rep; 2022; 8(5):194-198. PubMed ID: 36189134 [TBL] [Abstract][Full Text] [Related]
42. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359 [TBL] [Abstract][Full Text] [Related]
43. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene. Felderbauer P; Karakas E; Fendrich V; Bulut K; Werner I; Dekomien G; Klein W; Bartsch D; Schmidt WE Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):527-9. PubMed ID: 17853337 [TBL] [Abstract][Full Text] [Related]
44. Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism. Starker LF; Akerström T; Long WD; Delgado-Verdugo A; Donovan P; Udelsman R; Lifton RP; Carling T Horm Cancer; 2012 Apr; 3(1-2):44-51. PubMed ID: 22187299 [TBL] [Abstract][Full Text] [Related]
45. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1. Wang X; Lundblad J; Smith SM PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775 [TBL] [Abstract][Full Text] [Related]
46. Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism. Wystrychowski A; Pidasheva S; Canaff L; Chudek J; Kokot F; Wiecek A; Hendy GN J Clin Endocrinol Metab; 2005 Feb; 90(2):864-70. PubMed ID: 15572418 [TBL] [Abstract][Full Text] [Related]
47. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Cole DE; Janicic N; Salisbury SR; Hendy GN Am J Med Genet; 1997 Aug; 71(2):202-10. PubMed ID: 9217223 [TBL] [Abstract][Full Text] [Related]
57. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation. Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586 [TBL] [Abstract][Full Text] [Related]
58. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene. Marx SJ; Sinaii N J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168 [TBL] [Abstract][Full Text] [Related]
60. Glucocorticoid-responsive lymphocytic parathyroiditis and hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor: a case report and literature review. Song L; Liu L; Miller RT; Yan SX; Jackson N; Holt SA; Maalouf NM Eur J Endocrinol; 2017 Jul; 177(1):K1-K6. PubMed ID: 28515208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]